ILDONG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,060 KRW | -0.79% |
|
-0.92% | -17.07% |
| 05-22 | Dong-A ST to Become Second-Largest Shareholder of Idience in KRW25 Billion Deal | MT |
| 2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 308M | - | - | ||||
| 727B | ||||||
| 599B | ||||||
| 354B | ||||||
| 328B | ||||||
| 277B |
